| HOME >> MEDICINE >> TECHNOLOGY |
Three Months Ended Six Months Ended
September 30, September 30,
------------- -------------
2009 2008 2009 2008
---- ---- ---- ----
Gross Profit
GAAP gross
profit $2,451,401 $3,371,317 $4,725,360 $7,188,972
% of sales 82% 86% 81% 85%
Share-based
compensation 4,903 8,879 18,448 25,253
Depreciation
expense 14,150 13,057 28,299 25,847
------ ------ ------ ------
Non-GAAP
gross profit 2,470,454 3,393,253 4,772,107 7,240,072
--------- --------- --------- ---------
Operating
Expenses
GAAP
operating
expenses 3,328,495 3,962,936 6,973,962 8,238,179
Share-based
compensation 113,909 198,131 273,014 464,748
Depreciation
expense 57,546 62,104 115,623 119,161
Amortization
expense 211,503 210,966 423,316 421,941
------- ------- ------- -------
Non-GAAP
operating
expenses 2,945,537 3,491,735 6,162,009 7,232,329
--------- --------- --------- ---------
Operating
Loss
GAAP
operating
loss (877,094
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2009 PR Newswire. All rights reserved |